Position in CCCC
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$7
New position
Shares Held
3
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Position in Biotechnology
Healthcare · as of Jun 30, 2026HANTZ FINANCIAL SERVICES, INC. holds $21,275,017 across 57 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
15,883 | $4,781,259 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
58,496 | $4,578,481 | |
| 3 | ARGX |
Argenx SE
|
2,816 | $2,612,600 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
34,865 | $1,233,872 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
3,961 | $954,482 | |
| 6 | EXEL |
Exelixis, Inc.
|
16,074 | $874,586 | |
| 7 | CYTK |
Cytokinetics Inc
|
10,063 | $857,266 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
11,424 | $653,681 |
All Filings in CCCC
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7 | 3 | Shares | Sole | 2026-05-01 | |
| No filing history on record for this holder in this stock. | ||||||